MENUU-M Cancer Center names Alon Weizer new medical director
Written by Nicole Fawcett
ANN ARBOR, Mich. - The University of Michigan Rogel Cancer Center has named Alon Weizer, M.D., M.S., as medical director. In this role, Weizer will be responsible for managing the day-to-day clinical outpatient operations at the center.
Weizer is associate professor of urology at the U-M Medical School. His clinical and research interest focuses on prevention and early detection of bladder cancer, novel treatments for early bladder cancer, and the use of minimally invasive approaches to treat bladder, prostate, kidney, testicular and other genitourinary malignancies. He is also interested in the development of quality indicators for cancer care.
Weizer earned his medical degree from Baylor College of Medicine in Houston and completed a six-year training program in general surgery and urology at Duke University, where he was chief resident in urology. He then completed a urologic oncology and minimally invasive surgery fellowship at U-M before joining the faculty in 2007. He has also completed the master's program in clinical research design and statistical analysis at the University of Michigan School of Public Health.
The medical director position was formerly held by Douglas Blayney, M.D. Weizer will work closely with Kathleen Cooney, M.D., who in January was appointed deputy director for clinical services for the Cancer Center. Weizer's appointment is effective June 17.